United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
329.16
+0.49 (0.15%)
At close: Jul 19, 2024, 4:00 PM
334.02
+4.86 (1.48%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
United Therapeutics Employees
United Therapeutics had 1,168 employees as of December 31, 2023. The number of employees increased by 183 or 18.58% compared to the previous year.
Employees
1,168
Change (1Y)
183
Growth (1Y)
18.58%
Revenue / Employee
$2,138,955
Profits / Employee
$899,401
Market Cap
14.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,168 | 183 | 18.58% |
Dec 31, 2022 | 985 | 20 | 2.07% |
Dec 31, 2021 | 965 | 15 | 1.58% |
Dec 31, 2020 | 950 | 30 | 3.26% |
Dec 31, 2019 | 920 | 60 | 6.98% |
Dec 31, 2018 | 860 | 60 | 7.50% |
Dec 31, 2017 | 800 | 50 | 6.67% |
Dec 31, 2016 | 750 | 0 | - |
Dec 31, 2015 | 750 | 10 | 1.35% |
Dec 31, 2014 | 740 | 34 | 4.82% |
Dec 31, 2013 | 706 | 83 | 13.32% |
Dec 31, 2012 | 623 | 80 | 14.73% |
Dec 31, 2011 | 543 | 23 | 4.42% |
Dec 31, 2010 | 520 | 110 | 26.83% |
Dec 31, 2009 | 410 | 50 | 13.89% |
Dec 31, 2008 | 360 | 40 | 12.50% |
Dec 31, 2007 | 320 | 35 | 12.28% |
Dec 31, 2006 | 285 | 75 | 35.71% |
Dec 31, 2005 | 210 | 40 | 23.53% |
Dec 31, 2004 | 170 | 10 | 6.25% |
Dec 31, 2003 | 160 | 10 | 6.67% |
Dec 31, 2002 | 150 | 22 | 17.19% |
Dec 31, 2001 | 128 | 18 | 16.36% |
Dec 31, 2000 | 110 | 47 | 74.60% |
Dec 31, 1999 | 63 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Quest Diagnostics | 48,000 |
Viatris | 38,000 |
Molina Healthcare | 18,000 |
Revvity | 11,500 |
Medpace Holdings | 5,900 |
BioMarin Pharmaceutical | 3,401 |
Insulet | 3,000 |
Incyte | 2,524 |
UTHR News
- 12 days ago - United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis - Business Wire
- 23 days ago - Big Money Elevating United Therapeutics - FXEmpire
- 25 days ago - United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors - Business Wire
- 6 weeks ago - United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 2 months ago - United Therapeutics Corporation Reports First Quarter 2024 Financial Results - Business Wire
- 3 months ago - CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 3 months ago - United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 3 months ago - United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 - Business Wire